by Ubaka Ogbogu | Dec 16, 2010
Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns...
by Paul Krzyzanowski | Dec 14, 2010
One of the biggest choices graduate students and post-doctoral fellow face is whether to stay in academia or go into the business world. But what if the two weren’t really that different? Traditional advice about running a successful academic research group...
by Chris Kamel | Dec 9, 2010
Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as...
by David Kent | Dec 7, 2010
My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in...
by Stem Cell Network | Dec 1, 2010
Of all the projects we run out of our small admin office, certainly one of the more visually compelling is the Cells I See art contest. As a side event at the Network’s scientific meeting, Cells I See usually elicits a great deal of buzz, as conference attendees...
Comments